![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 42, 39343-39349, October 18, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
,
, and
**
From the Glucosamine is a naturally occurring derivative
of glucose and is an essential component of glycoproteins and
proteoglycans, important constituents of many eukaryotic proteins. In
cells, glucosamine is produced enzymatically by the amidation of
glucose 6-phosphate and can then be further modified by acetylation to result in N-acetylglucosamine. Commercially, glucosamine is
sold over-the-counter to relieve arthritis. Although there is evidence in favor of the beneficial effects of glucosamine, the mechanism is
unknown. Our data demonstrate that glucosamine suppresses the activation of T-lymphoblasts and dendritic cells in vitro
as well as allogeneic mixed leukocyte reactivity in a
dose-dependent manner. There was no inherent cellular
toxicity involved in the inhibition, and the activity was not
reproducible with other amine sugars. More importantly, glucosamine
administration prolonged allogeneic cardiac allograft survival in
vivo. We conclude that, despite its documented effects on insulin
sensitivity, glucosamine possesses immunosuppressive activity and could
be beneficial as an immunosuppressive agent.
Department of Surgery, T. E. Starzl Transplantation Institute, the Departments of ¶ Molecular
Genetics and Biochemistry and ** Pathology, and the
Diabetes Institute, University of Pittsburgh School of Medicine,
and the § Department of Pediatrics, Division of
Immunogenetics, Children's Hospital of Pittsburgh,
Pittsburgh, Pennsylvania 15213

To whom correspondence should be addressed: Dept. of Pathology,
Diabetes Inst., University of Pittsburgh School of Medicine, Rangos
Research Center 5102, 3460 Fifth Ave., Pittsburgh, PA 15213. Tel.:
412-692-8127; Fax: 412-692-8131; E-mail: Ngiann1@pitt.edu.
This article has been cited by other articles:
![]() |
A. Grigorian, S.-U. Lee, W. Tian, I.-J. Chen, G. Gao, R. Mendelsohn, J. W. Dennis, and M. Demetriou Control of T Cell-mediated Autoimmunity by Metabolite Flux to N-Glycan Biosynthesis J. Biol. Chem., July 6, 2007; 282(27): 20027 - 20035. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-T. Chen, J.-B. Liang, C.-L. Chou, M.-W. Chien, R.-C. Shyu, P.-I Chou, and D.-W. Lu Glucosamine Sulfate Inhibits TNF-{alpha} and IFN-{gamma}-Induced Production of ICAM-1 in Human Retinal Pigment Epithelial Cells In Vitro Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 664 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
B A Biggee, C M Blinn, T E McAlindon, M Nuite, and J E Silbert Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness Ann Rheum Dis, February 1, 2006; 65(2): 222 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-X. Zhang, S. Yu, B. Gran, and A. Rostami Glucosamine Abrogates the Acute Phase of Experimental Autoimmune Encephalomyelitis by Induction of Th2 Response J. Immunol., December 1, 2005; 175(11): 7202 - 7208. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |